Display Settings:

Format

Send to:

Choose Destination
    Protein Sci. 2008 Oct;17(10):1827-33. Epub 2008 Jul 2.

    Site-specific incorporation of unnatural amino acids into urate oxidase in Escherichia coli.

    Source

    School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.

    Abstract

    Urate oxidase catalyzes the oxidation of uric acid with poor solubility to produce 5-hydroxyisourate and allantoin. Since allantoin is excreted in vivo, urate oxidase has the potential to be a therapeutic target for the treatment of gout. However, its severe immunogenicity limits its clinical application. Furthermore, studies on the structure-function relationships of urate oxidase have proven difficult. We developed a method for genetically incorporating p-azido-L-phenylalanine into target protein in Escherichia coli in a site-specific manner utilizing a tyrosyl suppressor tRNA/aminoacyl-tRNA synthetase system. We substituted p-azido-L-phenylalanine for Phe(170) or Phe(281) in urate oxidase. The products were purified and their enzyme activities were analyzed. In addition, we optimized the system by adding a "Shine-Dalgarno (SD) sequence" and tandem suppressor tRNA. This method has the benefit of site-specifically modifying urate oxidase with homogeneous glycosyl and PEG derivates, which can provide new insights into structure-function relationships and improve pharmacological properties of urate oxidase.

    PMID:
    18596202
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2548377
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 1.
    Figure 3.
    Figure 5.
    Figure 2.
    Figure 4.

      Supplemental Content

      Icon for John Wiley & Sons, Inc. Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk